Accriva Diagnostics, headquartered in San Diego, California, is a leading hospital-focused point-of-care (POC) cardiovascular diagnostics company. The Company is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin.
Accriva Diagnostics was formed in 2013 through the merger of ITC, a Warburg Pincus portfolio company that was acquired from Thoratec in 2010, and Accumetrics, Inc.